Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Bioprospecting the antimicrobial, antibiofilm and antiproliferative activity of Symplocos racemosa Roxb. Bark phytoconstituents along with their biosafety evaluation and detection of antimicrobial components by GC-MS

Fig. 1

Inhibitory action of the Partially Purified Phytoconstituents of Symplocos racemosa bark on the a Initial cell attachment b Pre-formed biofilms of the test organisms c Metabolic activity of the biofilms.*EC-Escherichia coli; KP1- Klebsiella pneumoniae 1, CA- Candida albicans, SA- Staphylococcus aureus. Similar alphabetic letters on the bar columns before and after the comma represent no significant difference at 95% confidence level among different treatments for each organism and among test organisms for each treatment, respectively as indicated by One-way ANOVA followed by Tukey’s t-test

Back to article page